Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.
about
UK guidelines for the management of bone sarcomasSpinal osteosarcomaChordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.En bloc resection for primary and metastatic tumors of the spine: a systematic review of the literature.Differential proteomic profiling of chordomas and analysis of prognostic factors.Carbon ion radiotherapy for sacral chordomaSystemic therapy options for unresectable and metastatic chordomas.[Primary malignant bone tumors].Novel therapeutic targets in chordoma.Multiple craniocervical chordomas presenting as a parapharyngeal mass.Phase II study on lapatinib in advanced EGFR-positive chordoma.Benign notochordal cell tumors of the spine: natural history of 8 patients with histologically confirmed lesions.Dosimetric accuracy of proton therapy for chordoma patients with titanium implantsPreliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum.Multidisciplinary management of recurrent chordomas.Long-term outcome following surgical treatment of sacral chordoma.Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordomaStereotactic radiosurgery for primary malignant spinal tumors.Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients' shorter overall survival.Sacral Insufficiency Fractures are Common After High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.CORR Insights(®): Sacral Insufficiency Fractures are Common after High-dose Radiation for Sacral Chordomas Treated With or Without SurgeryImmunotherapy as a Potential Treatment for Chordoma: a Review.Safety and Local Control of Radiation Therapy for Chordoma of the Spine and Sacrum: A Systematic Review.Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan.Carbon Ion Radiotherapy: A Review of Clinical Experiences and Preclinical Research, with an Emphasis on DNA Damage/RepairUK Guidelines for the Management of Bone Sarcomas.Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-upNew strategies in radiation therapy: exploiting the full potential of protons.The value of image-guided intensity-modulated radiotherapy in challenging clinical settings.How Does the Level of Sacral Resection for Primary Malignant Bone Tumors Affect Physical and Mental Health, Pain, Mobility, Incontinence, and Sexual Function?Clinical controversies: proton therapy for pediatric tumors.Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.Strategy in the surgical treatment of primary spinal tumors.Helical tomotherapy of spinal chordomas: French Multicentric, retrospective study of a cohort of 30 casesPalliative therapy for osteosarcoma.Update on management of vertebral column tumors.
P2860
Q26752425-AD670B4F-796A-4D16-9883-06DF56536324Q26996533-7DB1D5DC-8162-49A6-A9D3-8CC817851122Q33273555-35411C17-03E2-4981-9E37-3F1E8552D64AQ33273872-0831A9F0-A74C-43AD-A98D-4771A746C2CAQ33273896-B88EA6CC-4598-4EC6-A429-BAE766748BD1Q33274097-912C7895-0E3B-4E61-96BA-4FF761F328C2Q33274146-2F54CB85-0434-482C-A808-9666EF39080FQ33274311-8EE93017-D23C-4152-A96C-B157E2B80985Q33274528-BE0F69E8-908F-4667-BE45-F62D38FE038FQ33274615-97539B6C-E46F-4582-B872-6D6FC03BA21BQ33274760-8674183A-CC92-4957-AC1F-FB51DB3CFC41Q33274810-993048FE-9D0D-41E1-B46B-C6D54C1F6BACQ33274841-68C68C2C-3A32-4BE2-AFD9-46DCAA2BE83FQ33274866-B03A328C-F9AB-4350-9626-779F82BEB933Q33274875-A4C7A1B3-2777-4FEA-81EE-BFEC6FC78DA2Q33275018-89068CE2-5C64-492A-BEA3-87A4F29904FDQ33275033-71AD63E6-1E10-471A-94A1-46167C3D9BE4Q33275240-0E410DA1-9790-4D01-B18B-9D7D3E50C1FEQ33275243-7A9D95AC-9589-462D-8D04-4C702553984EQ33275318-467B27B6-F471-479B-981A-6C44A7128859Q33275483-89B939F2-C6BB-4DBA-A09D-53AB8D04EC45Q33275565-D018203B-E0F5-4DCC-8EB9-9D67EC65FE1FQ33275755-40940269-317E-478B-B3EA-CEF562FBF918Q33275758-4DBE28FE-93FA-40B3-9C9A-8F2DE85F7D90Q33275795-77A1D084-F962-4BFB-AE5C-36E50D88A187Q33276143-51E9CEC4-B28C-4C1E-A544-1C8E4C4096D7Q33276169-F98CE278-9F9C-4107-A631-2D4C82CA13B1Q33276381-5D13ABFC-7E4B-4608-BCA4-AF7EED2EF4FDQ33832767-54FAAEEF-3F3D-4857-8EC1-F98B92777D7BQ34496992-EE5B7BA9-395B-4C08-A34B-C9D8C9028F70Q35639509-30DB44C5-432D-474A-BD1D-74F3DEA41418Q35990699-D9E4AAC4-AD21-4BB8-AB6D-69F3FC5AACCBQ36294866-4BB6E4CF-351C-43AA-8A51-92564DBC7B83Q36558776-03EE4B75-E8E2-44EA-9FB3-DFDA73332880Q36677257-F7F78372-EA1C-47F3-B164-315D0FF75D91Q37026245-2298AC86-5F48-4C81-A1C5-6D005D5CA42CQ37395535-BD813AA3-B547-44C2-B41B-B115611B29C0Q37615763-C949F50F-145E-4FAB-A3BB-211B5DF45978Q37845831-9A06FBEE-B9D4-4447-8476-D3BD0CF7E0BBQ38233173-4DF8F64B-A2EF-4FCE-B4EA-133CC17E3A82
P2860
Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase II study of high-dose ph ...... management of spine sarcomas.
@ast
Phase II study of high-dose ph ...... management of spine sarcomas.
@en
Phase II study of high-dose ph ...... management of spine sarcomas.
@nl
type
label
Phase II study of high-dose ph ...... management of spine sarcomas.
@ast
Phase II study of high-dose ph ...... management of spine sarcomas.
@en
Phase II study of high-dose ph ...... management of spine sarcomas.
@nl
prefLabel
Phase II study of high-dose ph ...... management of spine sarcomas.
@ast
Phase II study of high-dose ph ...... management of spine sarcomas.
@en
Phase II study of high-dose ph ...... management of spine sarcomas.
@nl
P2093
P2860
P50
P1476
Phase II study of high-dose ph ...... management of spine sarcomas.
@en
P2093
Beow Y Yeap
David C Harmon
Francis X Pedlow
G Petur Nielsen
Herman D Suit
Ira J Spiro
Judith Adams
Kevin A Raskin
Patricia McManus
Sam S Yoon
P2860
P304
P356
10.1016/J.IJROBP.2008.08.058
P407
P577
2008-12-25T00:00:00Z